NRF2 signalling in cytoprotection and metabolism
British Journal of Pharmacology · 2026-01 · 183 (1) · 101-114
DOI: 10.1111/bph.16246 ↗At a glance
Übersichtsarbeit in British Journal of Pharmacology, published online on 2023-10-16. Written by Shohei Murakami and 4 co-authors. Institution: Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan. Major MEDLINE topics: NF-E2-Related Factor 2, Signal Transduction, Cytoprotection. Cited 62 times so far (Crossref); 127 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Core Research for Evolutionary Science and Technology, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (original language)
The KEAP1 ‐ NRF2 system plays a central role in cytoprotection in defence mechanisms against oxidative stress. The KEAP1‐NRF2 system has been regarded as a sulfur‐utilizing cytoprotective mechanism, because KEAP1 serves as a biosensor for electrophiles by using its reactive thiols and NRF2 is a transcriptional factor regulating genes involved in sulfur‐mediated redox reactions. NRF2 is a key regulator of cytoprotective genes, such as antioxidant and detoxification genes, and also possesses potent anti‐inflammatory activity. Recently NRF2 has been the focus of attention as a regulator of cellular metabolism and mitochondrial function. The NRF2‐mediated regulatory mechanisms of metabolites and mitochondria have been considered diverse, but have not yet been fully clarified. This review article provides an overview of molecular mechanisms that regulate NRF2 signalling and its cytoprotective roles, and highlights NRF2 contribution to cellular metabolism, particularly in the context of mitochondrial function and newly‐found sulfur metabolism. LINKED ARTICLES This article is part of a themed issue Recent Innovations in Targeting Redox Biology for Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.1/issuetoc
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
- Department of Otolaryngology-Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID profiles: Hozumi Motohashi
Funding
- Core Research for Evolutionary Science and Technology
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Core Research for Evolutional Science and Technology
Cite
APA
Murakami, S., Kusano, Y., Okazaki, K., Akaike, T., & Motohashi, H. (2026). NRF2 signalling in cytoprotection and metabolism. British Journal of Pharmacology, 183(1), 101-114. https://doi.org/10.1111/bph.16246
Vancouver
Murakami S, Kusano Y, Okazaki K, Akaike T, Motohashi H. NRF2 signalling in cytoprotection and metabolism. British Journal of Pharmacology. 2026;183(1):101-114. doi:10.1111/bph.16246
BibTeX
@article{Murakami2026,
author = {Murakami, Shohei and Kusano, Yusuke and Okazaki, Keito and Akaike, Takaaki and Motohashi, Hozumi},
title = {NRF2 signalling in cytoprotection and metabolism},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {1},
pages = {101--114},
doi = {10.1111/bph.16246}
}
EUVIMED